Soltis R D, Hasz D E
J Clin Lab Immunol. 1982 Nov;9(2):121-31.
The ability of the 125I-C1q binding test to detect soluble antigen-antibody complexes formed in vitro was tested with two antigen-antibody systems. Using tetanus toxoid:anti-toxoid complexes, all of the increased 125I-C1q binding activity was due to soluble immunoglobulin aggregates present in the unheated tetanus immune globulin. Using BSA:anti-BSA complexes, maximum 125I-C1q binding activity was present in the soluble supernatants from the equivalence zone. No immune complexes were present in these supernatants and the increased activity appeared to be due to alterations in endogenous C1 during the formation of large, insoluble immune complexes. The 125I-C1q binding test readily detected large, insoluble BSA:anti-BSA complexes but may not detect small, soluble complexes which have been suggested to be important in disease pathogenesis.
采用两种抗原 - 抗体系统对¹²⁵I - C1q结合试验检测体外形成的可溶性抗原 - 抗体复合物的能力进行了测试。使用破伤风类毒素:抗类毒素复合物时,¹²⁵I - C1q结合活性的所有增加均归因于未加热的破伤风免疫球蛋白中存在的可溶性免疫球蛋白聚集体。使用牛血清白蛋白(BSA):抗BSA复合物时,等价区的可溶性上清液中存在最大¹²⁵I - C1q结合活性。这些上清液中不存在免疫复合物,活性增加似乎是由于在形成大的不溶性免疫复合物过程中内源性C1的改变所致。¹²⁵I - C1q结合试验很容易检测到大的不溶性BSA:抗BSA复合物,但可能检测不到已被认为在疾病发病机制中起重要作用的小的可溶性复合物。